Table 2 Prognostic factors for surgically treated spontaneous basal ganglionic hematoma
From: Surgical management for large hypertensive basal ganglionic hemorrhage: single center experience
Outcome | GOS 1–2 (n = 37) | GOS 3–5 (n = 29) | P value | ||
|---|---|---|---|---|---|
No. | % | No. | % | ||
Age (years) | |||||
< 20 | 5 | 83.3 | 1 | 16.7 | 0.050* |
20–40 | 16 | 69.6 | 7 | 30.4 | |
41–60 | 16 | 43.2 | 21 | 56.8 | |
Sex | |||||
Male | 26 | 55.3 | 21 | 44.7 | 0.849 |
Female | 11 | 57.9 | 8 | 42.1 | |
Neurological status on admission | |||||
GCS 5–8 | 3 | 14.3 | 18 | 85.7 | 0.000* |
GCS 9–12 | 21 | 70.0 | 9 | 30.0 | |
GCS 13–15 | 13 | 86.7 | 2 | 13.3 | |
Hematoma volume | |||||
30–60 ml | 26 | 86.7 | 4 | 13.3 | 0.000* |
61–90 ml | 7 | 41.2 | 10 | 58.8 | |
> 90 ml | 4 | 21.1 | 15 | 78.9 | |
Intraventricular extension | |||||
Yes | 3 | 27.3 | 8 | 72.7 | 0.048* |
No | 34 | 61.8 | 21 | 38.2 | |
Hydrocephalic dilation | |||||
Yes | 2 | 22.2 | 7 | 77.8 | 0.036* |
No | 35 | 61.4 | 22 | 38.6 | |
Midline shift | |||||
≤ 5 | 22 | 73.3 | 8 | 26.7 | 0.010* |
> 5 | 15 | 41.7 | 21 | 58.3 | |